Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Sep;19(9):1579-85.
doi: 10.1101/gr.094987.109. Epub 2009 Jun 8.

A method for rapid, targeted CNV genotyping identifies rare variants associated with neurocognitive disease

Affiliations

A method for rapid, targeted CNV genotyping identifies rare variants associated with neurocognitive disease

Heather C Mefford et al. Genome Res. 2009 Sep.

Abstract

Copy-number variants (CNVs) are substantial contributors to human disease. A central challenge in CNV-disease association studies is to characterize the pathogenicity of rare and possibly incompletely penetrant events, which requires the accurate detection of rare CNVs in large numbers of individuals. Cost and throughput issues limit our ability to perform these studies. We have adapted the Illumina BeadXpress SNP genotyping assay and developed an algorithm, SNP-Conditional OUTlier detection (SCOUT), to rapidly and accurately detect both rare and common CNVs in large cohorts. This approach is customizable, cost effective, highly parallelized, and largely automated. We applied this method to screen 69 loci in 1105 children with unexplained intellectual disability, identifying pathogenic variants in 3.1% of these individuals and potentially pathogenic variants in an additional 2.3%. We identified seven individuals (0.7%) with a deletion of 16p11.2, which has been previously associated with autism. Our results widen the phenotypic spectrum of these deletions to include intellectual disability without autism. We also detected 1.65-3.4 Mbp duplications at 16p13.11 in 1.1% of affected individuals and 350 kbp deletions at 15q11.2, near the Prader-Willi/Angelman syndrome critical region, in 0.8% of affected individuals. Compared to published CNVs in controls they are significantly (P = 4.7 x 10(-5) and 0.003, respectively) enriched in these children, supporting previously published hypotheses that they are neurocognitive disease risk factors. More generally, this approach offers a previously unavailable balance between customization, cost, and throughput for analysis of CNVs and should prove valuable for targeted CNV detection in both research and diagnostic settings.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
CNVs at 16p13.11 in individuals with ID. (A) SCOUT uses fluorescence intensity data generated for SNP genotypes, in this case at rs35597, to identify samples that harbor deletions or duplications. Each sample is assigned a score based on its intensity relative to the center of the cluster of all samples with the same genotype. Samples that harbor duplications exhibit greater total intensity and potentially aberrant allelic ratio (inferred genotypes marked in green), while deletions exhibit lesser intensity and lack SNP heterozygosity (inferred genotypes labeled in red). Samples analyzed as positive controls are labeled PC, while validated predictions are labeled as L1–L2 (“loss”) or G1–G9 (“gain”). Dashed circles are drawn manually for visual aid. Unlabeled samples that appear to be outliers at this probe are either outliers only at this probe or samples with insufficient DNA for validation. (B) SCOUT predictions were validated with targeted array-CGH experiments. Shown are the resulting data for the labeled samples in panel A, with normalized log-transformed test/reference ratios at each tested probe presented as vertical bars. Those probes that are more than 1.5 standard deviations above (below) the average for the entire array are colored green (red). The samples shown include eight validated duplications, two validated deletions, and one positive control deletion. Note that G9 was analyzed with a different array-CGH platform and is not shown here. Genome coordinates and segmental duplications are annotated at the top. The bottom shows RefSeq genes/isoforms annotated in this region.
Figure 2.
Figure 2.
SCOUT assigns highly negative scores to deletions (red), near-zero scores to diploid intervals (black), and highly positive scores to duplications (green). Normalized histograms (Y-axis indicates percent of each category) for known deletions (red, n = 35), predicted and validated deletions (dark red, n = 35), known duplications (green, n = 29), and predicted and validated duplications (dark green, n = 23) are shown. SCOUT scores are binned by 1-unit increments with the center of each bin labeled on the X-axis. The vast majority of scores correspond to diploid sites (n = 10,566 or 98.9%).
Figure 3.
Figure 3.
Reliability of SCOUT predictions as a function of threshold. Sensitivity (dashed lines/open squares) and false discovery rates (FDR, solid lines/solid squares) to detect deletions (red) and duplications (green) are plotted as a function of the absolute value of the SCOUT threshold, incremented by units of 0.25. These estimates exclude regions covered by only two probes and also exclude CNVs in positive control samples.

References

    1. Bailey JA, Gu Z, Clark RA, Reinert K, Samonte RV, Schwartz S, Adams MD, Myers EW, Li PW, Eichler EE. Recent segmental duplications in the human genome. Science. 2002;297:1003–1007. - PubMed
    1. Bijlsma EK, Gijsbers AC, Schuurs-Hoeijmakers JH, van Haeringen A, Fransen van de Putte DE, Anderlid BM, Lundin J, Lapunzina P, Perez Jurado LA, Delle Chiaie B, et al. Extending the phenotype of recurrent rearrangements of 16p11.2: Deletions in mentally retarded patients without autism and in normal individuals. Eur J Med Genet. 2009;52:77–87. - PubMed
    1. Brunetti-Pierri N, Berg JS, Scaglia F, Belmont J, Bacino CA, Sahoo T, Lalani SR, Graham B, Lee B, Shinawi M, et al. Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities. Nat Genet. 2008;40:1466–1471. - PMC - PubMed
    1. Butler MG, Bittel DC, Kibiryeva N, Talebizadeh Z, Thompson T. Behavioral differences among subjects with Prader-Willi syndrome and type I or type II deletion and maternal disomy. Pediatrics. 2004;113:565–573. - PMC - PubMed
    1. Carlson CS, Smith JD, Stanaway IB, Rieder MJ, Nickerson DA. Direct detection of null alleles in SNP genotyping data. Hum Mol Genet. 2006;15:1931–1937. - PubMed

Publication types

LinkOut - more resources